Tuberculosis (TB) caused by the intracellular pathogen, Mycobacterium tuberculosis (Mtb),
claims more than 1.5 million lives worldwide annually. Despite promulgation of multipronged …

Tuberculosis is the leading infectious disease responsible for an estimated one and a half
million human deaths each year around the globe. HIV-TB coinfection and rapid increase in …

Tuberculosis is an ever evolving infectious disease that still claims about 1.8 million human
lives each year around the globe. Although modern chemotherapy has played a pivotal role …

Background Globally, TB is the leading cause of infectious disease morbidity and mortality
with many diagnostic uncertainties. Access to affordable and rapid diagnostics remained a …

The in-vitro experimental model for the development of cancer therapeutics has always
been challenging. Recently, the scientific revolution has improved cell culturing techniques …

Increasing drug resistance in pathogens including Mycobacterium tuberculosis (MTB) has
been ascribed to mutations in the known target genes. However, many of these drugs have …

The global control of tuberculosis (TB) presents a continuous health challenge to mankind.
Despite having effective drugs, TB still has a devastating impact on human health …

Biomaterials have demonstrated their ability to serve as effective drug delivery platforms,
enabling targeted and localized administration of therapeutic agents. The development of …

Among all infectious diseases that afflict humans, tuberculosis (TB) remains the deadliest. At
present, epidemiologists estimate that one-third of the world population is infected with …

Cobalt (II) and copper (II) complexes of a series (E)-N'-(5-X-salicylidene)
isonicotinohydrazide Schiff bases derived from isonicotinic acid hydrazide and 5-substituted …